Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An announcement from Island Pharmaceuticals Ltd ( (AU:ILA) ) is now available.
Island Pharmaceuticals Ltd has announced that it currently has 27,319,837 listed options (ASX: ILAO) expiring on March 14, 2025, with an exercise price of $0.06 per option. The company advises holders of these options on how to exercise them before the expiration date. This announcement is significant for stakeholders, as it impacts the company’s financial operations and could affect investor decisions leading up to the expiration of these options.
More about Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd (ASX: ILA) is a drug repurposing company focused on developing antiviral therapeutics for infectious diseases. Their lead asset, ISLA-101, is intended for the prevention and treatment of dengue fever and other vector-borne diseases. The company aims to address unmet needs in antiviral treatments and may benefit from a Priority Review Voucher if ISLA-101 achieves FDA approval.
YTD Price Performance: -8.82%
Average Trading Volume: 237,023
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$28.21M
For a thorough assessment of ILA stock, go to TipRanks’ Stock Analysis page.
